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Introduction
Molecular recognition and sensing of nucleotides has been an
active research field over recent decades due to their biologi-
cal significance.[1] In addition to the well-known DNA, RNA and
co-factor nucleotides NAD (nicotinamide adenine dinucleotide
and FAD (flavin adenine dinucleotide), several nucleotide-relat-
ed molecules, such as cyclic diguanylate (c-di-GMP), cyclic ade-
nosine monophosphate (cAMP), diadenosine tetraphosphate
(Ap4A) and guanosine penta- or tetraphosphate (pppGpp or
ppGpp, respectively), are being actively investigated for their
role within second messenger signalling systems. These mole-
cules are produced by bacteria, along with quorum sensing
(QS) autoinducers, in response to environmental stimuli and, in
turn, lead to a variety of phenotypic changes that allow bacte-
ria to survive or even proliferate. In the post-antibiotic era,[2] it
is of outmost importance to acquire a detailed understanding
of how bacteria respond to stress to set out effective strategies
not only to prevent the insurgence of antibiotic resistance, but
also to eradicate recurrent and chronic infections.
Dissecting each signalling pathway requires the selective
detection of each such signalling molecule in a milieu over-
populated with many other, structurally similar, compounds.
We decided to focus our attention on ppGpp or pppGpp,
collectively known as (p)ppGpp, a signalling alarmone pro-
duced in response to stress conditions[3] (e.g. , heat shock,
nutrient starvation). Discovered in 1969 by Cashel and Gal-
lant,[4] they were initially nicknamed magic spot I and II, but,
even after their structures were elucidated (1; Figure 1), the
nickname lingered due to the complexity of the pleiotropic ef-
fects these molecules have on bacterial physiology.[5] Indeed,
(p)ppGpp impacts on transcription, translation and DNA repli-
cation,[3] and generates virulence factors by interfering with QS
networks.[6] Accumulation of (p)ppGpp is also upstream of the
stringent response, a signalling cascade implicated in the
formation of a dormant bacterial phenotype called persister.[7]
This phenotype, transiently tolerant to antibiotic treatment, is
not only largely responsible for the difficulties encountered in
eradicating recurrent and chronic infections, but also favours
the insurgence of resistant strains.
In the course of our research project on small molecules
able to control the onset of the persistent phenotype by inter-
fering with the stringent response pathway, selective detection
of (p)ppGpp has become a critical factor. Detection of
(p)ppGpp in solution historically relied on radiolabelled com-
pounds (either with 3H or 32P)[8] or HPLC methods.[9] Only in
recent years has a fluorescent chemosensor (PyDPA; Fig-
ure 1)—a compound bearing a binding moiety connected to
and communicating with a fluorophore[10]—been specifically
designed to bind selectively (p)ppGpp over other nucleotides,
such as ATP, GTP, UTP, TTP, cAMP and cGMP.[11]
From a structural point of view, PyDPA comprises two Zn2+
–dipicolylamine (Zn2+-DPA) units, which are well known for
their ability to bind pyrophosphate groups in water,[12] bridged
to a pyrene moiety through an alkyloxy phthalate. One mole-
cule of (p)ppGpp, with its two terminal pyrophosphate groups,
is able to chelate two molecules of PyDPA, thus forcing the
proximity of the corresponding pyrene units, which are exploit-
ed for their distinctive excimer emission (lem=470 nm).
[13]
Quantification of (p)ppGpp in solution is therefore possible
with an appropriate calibration curve up to the low-micro-
molar range.
Guanosine penta- or tetraphosphate (pppGpp or ppGpp, re-
spectively) is a nucleotide signalling molecule with a marked
effect on bacterial physiology during stress. Its accumulation
slows down cell metabolism and replication, supposedly lead-
ing to the formation of the antibiotic-tolerant persister pheno-
type. A specifically tailored fluorescent chemosensor, PyDPA,
allows the detection of (p)ppGpp in solution with high selec-
tivity, relative to that of other nucleotides. Herein, an optimised
synthetic approach is presented that improves the overall yield
from 9 to 67% over 7 steps. The simplicity and robustness of
this approach will allow groups investigating the many facets
of (p)ppGpp easy access to this probe.
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The synthesis of PyDPA, as originally reported in 2008 by
Rhee and co-workers,[11] was achieved in a modest yield of
about 9% over 6 steps, starting from 1-bromopyrene (2 ;
Scheme 1), whereas a marginal improvement to the overall
yield was reported a few years later by the same group,[14]
starting from 1-pyrenecarboxaldehyde (19% over 8 steps).
Herein, we report an optimised synthetic sequence that over-
comes the critical steps of the original and modified synthetic
approaches to increase the overall yield from 9–19 to 67%
over 7 steps.
Results and Discussion
The synthesis of Rhee et al. is outlined in Scheme 1. Halogen–
lithium exchange on 2 (nBuLi), followed by treatment with 1,3-
dibromopropane yields the monoarylation product 3, which is
used to alkylate 5-hydroxyisophthalic acid dimethyl ester. Ester
reduction (LiAlH4) and reaction of the resulting diol with PBr3
affords dibromide 4. Alkylation of DPA with 4 affords the struc-
ture of the ligand, which is finally transformed in the Zn com-
plex upon treatment with ZnClO4. All steps are described to
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Figure 1. Left) Structure of the nucleotide signalling molecule (p)ppGpp and of its specific chemosensor PyDPA. Right) Structure of the 2:1 PyDPA/ppGpp
complex.
Scheme 1. Reported synthesis of PyDPA, according to ref. [11] .
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proceed in good to excellent yields, except for the first one,
which proceeds with a modest yield of 18%, thus undermining
the whole synthetic sequence.
To improve on these results, we envisaged exploiting the
reactivity of the C@Br bond of 2 to perform a palladium-cata-
lysed coupling reaction with dimethyl-5-propargyloxy-iso-
phthalate (5 ; Scheme 2), under Sonogashira conditions. Differ-
ent Pd sources ([PdCl2(PPh3)2] or [Pd(PPh3)4]), in the presence
or absence of copper salts (CuI), different solvents (e.g. , tertiary
amines, THF, DMF) and a range of reaction temperatures (from
40 to 90 8C) were explored without success. Indeed, the high
activation temperatures required to activate the C@Br bond
were not compatible with the thermal instability of alkyne 5
and either no conversion of the starting material or alkyne de-
composition was observed.
The use of more reactive 1-iodopyrene (6)[15] allowed desired
product 7 to be obtained under mild conditions, although in
modest yield (42%), but it also introduced an additional step
to the synthetic sequence, which reduced the overall yield to
35% (Scheme 2).
Finally, a sequential approach was adopted to introduce the
alkynyl chain first and form the ether linkage at a later stage.
Although classical Sonogashira conditions are described as
being effective for the reaction of propargyl alcohol (8) with
2,[16] in our hands only copper-free conditions, with [Pd(PPh3)4]
as a catalyst in nBuNH2 at reflux, gave the desired product 9 in
excellent yield (94%; Scheme 3).[17] It is worth noting that the
same reaction conditions applied to phthalate 5 only resulted
in alkyne decomposition and a mixture of unidentified by-
products. Catalytic reduction of the triple bond of 9 has been
described with PtO2 (15 mol%) in THF,
[18] but we found that
much cheaper Pd/C in methanol worked just as well, with a
lower catalyst loading (5 mol%) and shorter reaction times
(20 min); thus resulting in an overall dramatic decrease in the
reaction cost.
Finally, the reaction of alcohol 10 with HBr/AcOH under MW
irradiation, as described in ref. [19] with modifications, pro-
ceeded smoothly to afford bromide 3 in quantitative yield
(Scheme 3). Alternative conditions involving the use of PBr3 for
functional group transformation provided lower yields and
complicated the reaction workup. Thus, compared with the re-
ported procedure, we obtained the same intermediate 3 in an
overall yield of 92%, as opposed to 18%. Two additional steps
are required, but only one chromatographic purification is in-
volved over the three steps.
At this stage, to increase the convergence of the synthetic
path and to skip the carboxymethyl ester reduction step that
was described to proceed in 68% yield (Scheme 1), triol 11
was used for the synthesis of ether 13, exploiting the lower
pKa of the phenol moiety (Scheme 4). The triol could be
obtained in almost quantitative yield through the reduction of
commercially available dimethyl 5-hydroxyisophthalate (12)
with LiAlH4.
[19] Alkylation of 11 with 3 was best performed with
an excess of K2CO3 and one equivalent of KI in acetonitrile at
reflux. Under these conditions, ether 13 was isolated in 95%
yield, after 17 h.
The final steps of the synthetic process were reproduced as
previously described, with comparable yields (Scheme 4). Diol
13 was therefore treated with PBr3 to afford dibromide 4
(89%), which gave 14 upon reaction with excess bis(2-picolyl)-
amine (88%). Treatment of 14 with Zn(ClO4)2·6H2O allowed
chemosensor PyDPA, which was used for (p)ppGpp detection
without further purification.
Spectral data
The spectral properties of PyDPA, including absorption and
fluorescence spectra, in the presence of ppGpp were consis-
tent with data reported in the literature for the PyDPA chemo-
sensor (Figure 2).
Indeed, whereas the presence of ppGpp led to the distinc-
tive excimer emission band at l=470 nm, the presence of
other nucleotides, such as AMP, GDP or ATP, only showed the
monomer emission bands.
Scheme 2. Palladium-mediated coupling of 1-iodopyrene (6) with isophtha-
late 5. TEA: triethylamine.
Scheme 3. Optimised approach for the preparation of 1-(3-bromopropyl)pyrene (3). MW: microwave.
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Conclusion
We have been able to streamline the synthesis of the PyDPA
chemosensor, overcoming the critical steps of the original syn-
thetic approach and increasing the overall yield from 9 to 67%
from the same starting material (2). We believe that this ap-
proach will be easily reproducible and useful for many groups
throughout the world that are investigating the biological
activity of the still puzzling nucleotide signalling molecule
(p)ppGpp.
Experimental Section
General : Chemicals were purchased from commercial sources and
used without further purification, unless otherwise indicated. If an-
hydrous conditions were required, the reactions were performed
under nitrogen or argon. Anhydrous solvents were purchased from
Merck. Reactions were monitored by means of analytical TLC per-
formed on silica gel 60 F254 plates (Merck) with UV detection (l=
254 nm) and/or staining with a solution of ammonium molybdate
acid or alkaline potassium permanganate. Silica gel 60 (40–63 mm;
Merck) was used for flash column chromatography. NMR spectros-
copy measurements were recorded on a Bruker AVANCE-400 MHz
instrument at 298 K. Chemical shifts are reported in ppm. The 1H
and 13C NMR resonances of compounds were assigned with the as-
sistance of COSY and HSQC experiments. Multiplicity is assigned as
s (singlet), d (doublet), t (triplet), q (quartet), quint (quintet) and m
(multiplet). Mass spectra were recorded on Apex II ICR FTMS (ESI
ionisation HRMS), Waters Micromass Q-TOF (ESI ionisation HRMS)
or ThermoFischer LCQ instruments (ESI ionisation). Compound 11
was prepared as described in ref. [19].
Synthesis of 3-Pyren-1-yl-prop-2-yn-1-ol (9): 1-Bromopyrene (2 ;
100 mg, 0.35 mmol) was dissolved with [Pd(PPh3)4] (13 mg,
0.0105 mmol) in nBuNH2 (12 mL) degassed with Ar. Compound 8
(102 mL, 1.78 mmol) was added to the mixture and the reaction
was left to stir at reflux. After 3 h the reaction was complete (TLC:
hexane/EtOAc 2:1). The solvent was evaporated under reduced
pressure and the crude product was purified by means of automat-
ed flash chromatography (hexane/EtOAc gradient from 92:8 to
40:60). Product 9 was obtained as a slightly yellow solid (85.1 mg,
95%). Spectral data matched those reported in ref. [17]. 1H NMR
(400 MHz, CDCl3): d=8.55 (d,
3J=9.2 Hz, 1H; H3Ar), 8.25–8.19 (m,
2H; H6Ar, H8Ar), 8.19–8.15 (m, 2H; H5Ar, H9Ar), 8.14–8.01 (m, 4H; H2Ar,
H4Ar, H7Ar, H10Ar), 4.52 (d,
3J=6.5 Hz, 2H; CH2OH), 1.82 ppm (t, 1H;
OH); 13C NMR (100 MHz, CDCl3): d=132.2 (C1), 131.5 (C5a), 131.3
(C8a), 131.1 (C3a), 129.9 (C10a), 128.5 (C2), 128.4 (C9), 127.3 (C5), 126.4
(C4), 126.2 (C7), 126.9 (C5a’), 126.7 (C3a’), 125.7 (C6), 125.5 (C8), 124.5
(C10), 124.4 (C3), 92.9 (C/CH2OH), 52.2 (CH2OH), 84.9 ppm
(CCH2OH); MS (ESI): m/z : calcd for [C19H12ONa]
+ : 279.08, found:
279.28.
Synthesis of 3-(pyren-1-yl)propan-1-ol (10): Compound 9
(184 mg, 0.72 mmol) was dissolved in freshly distilled MeOH
(24 mL). 10% Pd/C (38 mg, 0.04 mmol) was added and the reaction
mixture was stirred under hydrogen (1 atm) for 20 min (TLC:
hexane/AcOEt 6:4). The catalyst was removed by filtration through
Celite and the solvent was evaporated under reduced pressure to
give pure product 10 (179 mg, 96%). Spectral data matched those
reported in ref. [20]. 1H NMR (400 MHz, CDCl3): d=8.32 (d,
3J=
9.4 Hz, 1H; H3Ar), 8.19–8.15 (dd,
3J=7.5 Hz, 2H; H6Ar, H8Ar), 8.14–8.09
(dd, 3J=7.9 Hz, 2H; H2Ar, H9Ar), 8.06–8.01 (m, 2H; H4Ar, H5Ar), 7.99 (t,
1H; H7Ar), 7.90 (d, 1H; H10Ar), 3.80 (t,
3J=6.1 Hz, 2H; CH2OH), 3.50–
3.43 (m, 2H; ArCH2), 2.18–2.10 ppm (m, 2H; CH2CH2OH);
13C NMR
(100 MHz, CDCl3): d=136.3 (C1), 131.6 (C5a), 131.0 (C8a), 131.1 (C3a),
128.8 (C10a), 127.7 (C2), 127.6 (C9), 127.5 (C5), 127.4 (C4), 126.2 (C7),
125.4 (C5a’), 125.3 (C3a’), 125.1 (C6), 125.0 (C8), 124.9 (C10), 123.4 (C3),
62.6 (CH2OH), 34.7 (ArCH2), 29.8 ppm (CH2-CH2OH); MS (ESI): m/z :
[C19H16ONa]
+ : 283.10; found: 282.96.
Synthesis of 1-(3-bromopropyl)pyrene (3): 33% HBr in AcOH
(0.8 mL) was added to alcohol 10 (179 mg, 0.68 mmol) in a micro-
Scheme 4. Preparation of compound 13 through the alkylation of phenol 11 with compound 3 and the final steps of the synthesis of PyDPA.
Figure 2. Fluorescence emission spectra of PyDPA (20 mm in 1 mm HEPES
pH 7.5) alone and upon the addition of each nucleotide and ppGpp (7 mm).
lex=344 nm.
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wave vial. The reaction was stirred under MW irradiation at 100 8C
for 45 min (TLC: hexane/AcOEt 7:3). The reaction mixture was dilut-
ed with EtOAc (15 mL) and the organic phase was washed with a
50% solution of NaHCO3 (3V15 mL) and water (1V15 mL), and
then dried over anhydrous Na2SO4. The solvent was evaporated
under reduced pressure to give pure product 3 as a brown viscous
oil (218 mg, quant.) Spectral data matched those reported in the
literature.[20] 1H NMR (400 MHz, CDCl3): d=8.29 (d,
3J=9.2 Hz, 1H;
H3Ar), 8.20–8.15 (dd,
3J=7.6 Hz, 2H; H6Ar, H8Ar), 8.15–8.10 (dd,
3J=
7.7 Hz, 2H; H2Ar, H9Ar), 8.03 (s, 2H; H4Ar, H5Ar), 7.99 (t, 1H; H7Ar), 7.90
(d, 1H; H10Ar), 3.56–347 (m, 4H; CH2OH, ArCH2), 2.41 ppm (quint,
3J=6.9 Hz, 2H; CH2CH2OH);
13C NMR (100 MHz, CDCl3): d=134.9
(C1), 131.6 (C5a), 131.3 (C3a), 131.0 (C8a), 128.8 (C10a), 127.7 (C2), 127.6
(C9), 127.0 (C5), 126.0 (C4), 125.2 (C7), 125.1 (C6), 125.0 (C8, C5a’),
124.9 (C10), 123.4 (C3), 123.3 (C3a’), 34.7 (H2C-CH2Br), 33.6 (CH2Br),




nol (13): Compounds 3 (100 mg, 0.31 mmol), 11 (57.2 mg,
0.37 mmol), oven-dried K2CO3 (128 mg, 0.93 mmol) and KI (56 mg,
0.34 mmol) were dissolved in dry CH3CN (2 mL, 0.15m). The reac-
tion mixture was stirred at reflux under MW irradiation for 17 h
(TLC: CH2Cl2/MeOH 95:5). The solvent was evaporated under re-
duced pressure and the resulting brown solid was dissolved in
EtOAc (15 mL). The solution was washed with water (3V5 mL) and
brine (1V15 mL). The organic phase was dried over anhydrous
MgSO4 and the solvent was evaporated under reduced pressure.
The crude was purified by means of automated flash chromatogra-
phy (95:5 CH2Cl2/MeOH) to afford pure 13 (116.3 mg, 95%). Spec-
tral data matched those previously reported.[11] 1H NMR (400 MHz,
CDCl3): d=8.32 (d,
3J=9.6 Hz, 1H; H3Ar), 8.17 (d,
3J=7.6 Hz, 2H;
H6Ar, H8Ar), 8.13–8.07 (dd,
3J=7.7 Hz, 2H; H2Ar, H9Ar), 8.03 (s, 2H; H4Ar,
H5Ar), 7.99 (t, 1H; H7Ar), 7.90 (d, 1H; H10Ar), 6.95 (s, 1H; Hp-Ph), 6.87
(s, 2H; Ho-Ph), 4.67 (s, 4H; CH2OH), 4.07 (t,
3J=6.1 Hz, 2H;
CH2OPh), 3.56 (t,
3J=7.4 Hz, 2H; ArCH2), 2.35 ppm (quint, 2H;
ArCH2CH2) ;
13C NMR (100 MHz, CDCl3): d=159.7 (Cq-OCH2), 142.9
(2VCq), 135.9 (C1), 131.6 (C5a), 131.0 (C8a), 130.1 (C3a), 128.9 (C10a),
127.6 (C2), 127.5 (C9), 127.4 (C5), 126.8 (C4), 126.0 (C7), 125.3 (C5a’),
125.1 (C3a’), 125.0 (C6, C8), 124.9 (C10), 123.5 (C3), 117.6 (CHp-Ph),
112.4 (2VCHo-Ph), 67.1 (CH2OPh), 65.3 (2VCH2OH), 31.3 (ArCH2CH2),
29.9 ppm (ArCH2) ; MS (ESI): m/z : calcd for [C27H24O3Na]
+ : 419.16;
found: 419.64.
Chemosensor PyDPA : 1H NMR (400 MHz, CD3CN): d=8.76–8.72 (d,
3J=5.3 Hz, 4H; CH-o-Py), 8.37 (d, 3J=9.2 Hz, 1H; H3Ar), 8.21–8.09
(m, 3H; H6Ar, H8Ar, H9Ar), 8.07–7.90 (m, 9H; H2Ar, H4Ar, H5Ar, H7Ar, H10Ar,
CH-p-Py), 7.67 (t, 3J=6.3 Hz, 4H; CH-m-Py), 7.33 (d, 3J=7.8 Hz, 4H;
CH-m’-Py), 6.73 (s, 2H; Ho-Ph), 6.71 (s, 1H; Hp-Ph), 4.16 (d, Jgem=
16 Hz, 4H; PyCH2N), 4.02 (t,
3J=5.5 Hz, 2H; ArCH2CH2CH2O), 3.82 (s,
4H; NCH2Ph,), 3.64 (d, 4H; PyCH2N), 3.61 (t,
3J=7.3 Hz, 2H;
ArCH2CH2CH2O), 2.36 ppm (quint,
3J=6.9 Hz, 2H; ArCH2CH2CH2O);
13C NMR (100 MHz, CD3CN): d=160.4 (Cq-OCH2), 155.4 (Cq Py),
149.1 (Co Py), 143.0 (Cp Py), 137.3 (2x Cq Ph), 134.3 (C1), 132.3 (C5a),
131.8 (C8a), 130.9 (C3a), 129.8 (C10a), 129.0 (C2), 128.5 (C9), 128.2 (C5),
127.7 (C4), 127.4 (2xCHo-Ph), 127.2 (C7), 126.4 (CH-m-Py), 126.1 (C10),
126.0 (CH-m’-Py), 126.0 (C6), 125.8 (C8), 125.7 (C5a’), 125.5 (C3a’),
124.7 (C3), 119.0 (CHp-Ph), 68.0 (ArCH2CH2CH2OPh), 56.9 (PhCH2N),
55.8 (PyCH2N), 31.9 (ArCH2CH2CH2OPh), 29.8 ppm




@]+ : 1187.07; found: 1187.28.
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